CervoMed Stock Forecast

CRVO's stock price has decreased by -60.7% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 7 analysts polled by S&P Global, CervoMed stock has a consensus rating of "Strong Buy" and an average price target of $20.33. The average 1-year stock price forecast is 591.50% higher than the current stock price, while the lowest is $9.00 (+206.12%) and the highest is $27 (+818.37%).

Price Target: $20.33 (+591.50%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$9.00	$20.33	$20.5	$27
Change	+206.12%	+591.50%	+597.28%	+818.37%

Analyst Ratings

The average analyst rating for CervoMed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	8	8	8	8	8	7
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	8	8	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ram Selvaraju H.C. Wainwright	H.C. Wainwright	Buy Reiterates $25	Buy	Reiterates	$25	+750.34%	May 26, 2026
Sumant Kulkarni Canaccord Genuity	Canaccord Genuity	Buy Reiterates $27	Buy	Reiterates	$27	+818.37%	May 19, 2026
Boris Peaker JonesTrading	JonesTrading	Buy Maintains $20	Buy	Maintains	$20	+580.27%	May 19, 2026
Boobalan Pachaiyappan Roth MKM	Roth MKM	Buy Reiterates $9	Buy	Reiterates	$9	+206.12%	May 18, 2026
Daniil Gataulin Chardan Capital	Chardan Capital	Buy Reiterates $21	Buy	Reiterates	$21	+614.29%	May 18, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

228.57K

from 4.01M

-94.30%

from 4.01M

Revenue Next Year

714.29K

from 228.57K

212.50%

from 228.57K

EPS This Year

-2.68

from -2.98

EPS Next Year

-2.42

from -2.68

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	7.14M	9.74M	4.01M	228.57K
Revenue Growth	-	-	-	36.29%	-58.86%	-94.30%
Operating Income	-5.04M	-3.48M	-7.81M	-18.23M	-28.29M	-38.89M
Net Income	-4.14M	-5.80M	-2.17M	-16.29M	-26.97M	-38.17M
EPS	-	-	-	-	-2.98	-2.68
Free Cash Flow	-	-1.33M	-4.73M	-10.69M	-13.31M	-37.10M
No. Analysts	-	-	-	-	-	7

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	1.6M
Avg	228,570
Low	n/a

Revenue Growth

Revenue Growth	2026	2027	2028
High	-60.1%
Avg	-94.3%
Low	-100.0%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-2.68
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-